Coexpression of cyclin D1 and retinoblastoma gene product (pRb) in human squamous cell lung carcinomas is associated with increased tumor take rate in nude mice

International Journal of Oncology

Volumn 9, Issue 6, 1996, Pages 1253-1257

  Volm, Manfred ^a   Stammler, Gerd ^a   Koomägi, Reet ^a   Mattern, Jürgen ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

cyclin D1; human lung carcinomas; nude mice; retinoblastoma gene; survival; tumor take rate

Indexed keywords

CYCLIN D1; RETINOBLASTOMA PROTEIN;

ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029827132     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.6.1253     Document Type: Article

References (20)

1. Sherr CJ: Mammalian G1 cyclins. Cell 79: 551-555, 1994.
2. Cordon-Cardo C: Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia (review). Am J Pathol 147: 545-560, 1995.
3. Lammie GA and Peters G: Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3: 413-420, 1991.
4. Keyomarsi K and Pardee AB: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90: 1112-1116, 1993.
5. Schauer IE, Siriwardana S, Langan TA and Sclafani RA: Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. Proc Natl Acad Sci USA 91: 7827-7831, 1994.
6. Mittnacht S and Weinberg RA: G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65: 381-393, 1991.
7. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM and Nevins JR: The E2F transcription factor is a cellular target for the RB protein. Cell 65: 1053-1061, 1991.
8. Johnson DJ, Schwarz JK, Cress WD and Nevins JR: Expression of transcription factor E2F1 induces quiescent cells to enter S-phase. Nature 365: 349-352, 1993.
9. World Health Organization: Histological typing of lung tumors. Tumori 6: 253-272, 1981.
10. Carr DT and Mountain CF: Staging lung cancer. In: Lung Cancer. Clinical Diagnosis and Treatment. Strauss MJ (ed). Grune and Stratton, New York, pp 151-161, 1977.
11. Volm M, Bak M, Efferth T, Lathan B and Mattem J: Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4. Anticancer Res 8: 531-536, 1988.
12. Volm M, Mattern J and Samsel B: Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein, and glutathione S-transferase-π in human lung tumors. Cancer 71: 3181-3187, 1993.
13. Fleiss JL (ed): Statistical Methods for Rates and Proportion. John Wiley, New York, 1973.
14. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Amer Statist Assn 53: 457-481, 1958.
15. Dutta A, Chandra R, Leiter LM and Lester S: Cyclins as marker of tumor proliferation: immunocytochemical studies in breast cancer. Proc Natl Acad Sci USA 92: 5386-5390, 1995.
16. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E and Balm A: Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975-978, 1995.
17. Michalides R, Hageman P, van Tinteren H, Houben L, Wientjens E, Klompmaker R and Peterse J: A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 73: 728-734, 1996.
18. Seshadri R, Lee CSL, Hui R, McCaul K, Horsfall DJ and Sutherland RL: Cyclin D1 amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. Clin Cancer Res 2: 1177-1184, 1996.
19. Betticher DC, Heighway J, Hasleton PS, Altermatt JH, Ryder WDJ, Cerny T and Thatcher N: Prognostic significance of CCND1 (cyclin D1) overexpression in primary non-small cell lung cancer. Br J Cancer 73: 294-300, 1996.
20. INK4a expression in resected non-small cell lung tumors. Cancer Res 56: 3415-3420, 1996.